Dr Shweta Dubey

Associate Professor

Amity Institute Of Virology & Immunology
 
  • Academic Area

    Immunology

  • Teaching Interests

    Fundamentals of Immunology Immune mechanisms in cancer & autoimmunity Bio therapeutics and vaccines
  • Qualifications

    Graduation : B.Sc(Zoology, Botany, Chemistry)-1996,Allahabad University

    Post Graduation : M.Sc(Biotechnology)-1999,Banasthali Vidyapeeth, Rajasthan

    Doctorate : Ph.D.(Immunology)-2004,Sanjay Gandhi P.G. Institute of Medical Sciences, Lucknow

  • Experience

    25 Jul 2011 - Present
    Associate Professor,
    Amity Institute Of Virology & Immunology

    01 Nov 2007 - 20 Jul 2011
    Sr. Scientist,
    Biopharmaceutical Research Centre, Panacea Biotech Ltd.,
    New Delhi

    01 Apr 2006 - 20 Oct 2007
    Research Scientist,
    Virology Group International Centre for Genetic Engg. & Biotechnology,
    -



  • Research Interests

    Immune mechanisms in cancer & autoimmunity Bio therapeutics and vaccines
  • Publications

    Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu ,
    American Society of Immunology

    Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians ,
    Elsevier

    Putting T cells to sleep: a new paradigm for immune evasion by persistent viruses ,
    Indian Academy of Science

    Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. ,
    Springer Link

    Involvement of Fas and TNF pathways in the induction of apoptosis of T cells by Antithymocyte globulin ,
    SpringerLink

    Induction of apoptosis of peripheral blood mononuclear cells by antithymocyte globulin (ATG) in aplastic anemia: an in vivo and in vitro study ,
    Springer Link

    autoantigens and defects in immune tolerance in Lupus ,
    Lippincott Williams and Wilkins;: .

    Autoantigeneisis and antigen based therapy and vaccination in SLE ,
    Elsevier

    Immune tolerance defects in Lupus ,
    Elsevier

    Identification of a novel glucokinase mutation in an Indian woman with GCK-MODY ,
    ISSN: 2213-8587

    Survivin: a unique target for tumor therapy ,
    Springer

    Identification of a novel glucokinase mutation in an Indian woman with GCK-MODY ,
    Elsevier

    Survivin a unique target for tumor therapy ,
    Biomed Central

    Releasing the brakes in Cancer ,
    Omics

  • Projects

    Immunomodulation by MIP in murine model of breast cancer(Talwar research foundation)
    Breast cancer is amongst the most common life threatening malignancies in women. Worldwide, breast cancer comprises 22.9% of all cancers in women (World Cancer Report, 2008). Whereas, the primary tumour can be efficiently treated by a combination of standard therapies, preventing the metastatic spread of the disease through disseminated tumour cells is currently ineffective. The eradication of disseminated tumour cells present in blood circulation and in various organs, where they form distant by (DST)

    Characterization of T cell activation and role of Tfh cells in multiple myeloma(AIIMS)
    This project ahs been approved by project review committe of ICMR and funding details are awaited. This projects aims to explore the role of T cells in pathogenesis of multiple myeloma.by (ICMR)

    Characterization of T cell activation and role of Tfh cells in multiple myeloma(AIIMS)
    This project ahs been approved by project review committe of ICMR and funding details are awaited. This projects aims to explore the role of T cells in pathogenesis of multiple myeloma.by (ICMR)

  • Affiliations

    Indian Immunology Society Since 01 May 2012

  • Activities

    American association of Immunologists travel award for developing countries, International Congress of Immunology, Milan, August 22-27th, 2013.

    Meyers Young Investigator fellowship from Arthritis foundation, Southern California Chapter, June 2005 -June 2006.Federation of Clinical Immunology Society (FOCIS)

    Trainee satellite symposium award presented by Genentech and UCB Pharma, FOCIS meeting, San Francisco, June 1-6, 2006.

  • Patents

    TUMOR NECROSIS FACTOR INHIBITING PEPTIDES AND USES THEREOF ,,United States - Complete ( United States Patent Application 20120010158 )

  • Conferences attended

    FOCIS meeting 2006
    Organized By :Federation of Clinical Immunology society

    AIDS in India
    Organized By :AIDS International Training and Research Program (AITRP), Albert Einstein College of Medicine

    Immunology
    Organized By :International union of Immunology Societies

  • Short Description

    I have done PhD in Immunology from SGPGIMS Lucknow (2004) and have been working since then in industry or academic institutes in various areas of Immunology.